1. Home
  2. PPBT vs STKH Comparison

PPBT vs STKH Comparison

Compare PPBT & STKH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • STKH
  • Stock Information
  • Founded
  • PPBT 2010
  • STKH 2018
  • Country
  • PPBT Israel
  • STKH Israel
  • Employees
  • PPBT N/A
  • STKH N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • STKH Packaged Foods
  • Sector
  • PPBT Health Care
  • STKH Consumer Staples
  • Exchange
  • PPBT Nasdaq
  • STKH Nasdaq
  • Market Cap
  • PPBT 2.1M
  • STKH 2.1M
  • IPO Year
  • PPBT N/A
  • STKH 2021
  • Fundamental
  • Price
  • PPBT $0.57
  • STKH $4.95
  • Analyst Decision
  • PPBT Strong Buy
  • STKH
  • Analyst Count
  • PPBT 1
  • STKH 0
  • Target Price
  • PPBT $33.00
  • STKH N/A
  • AVG Volume (30 Days)
  • PPBT 2.8M
  • STKH 419.4K
  • Earning Date
  • PPBT 08-06-2025
  • STKH 08-29-2025
  • Dividend Yield
  • PPBT N/A
  • STKH N/A
  • EPS Growth
  • PPBT N/A
  • STKH N/A
  • EPS
  • PPBT N/A
  • STKH N/A
  • Revenue
  • PPBT N/A
  • STKH $10,000.00
  • Revenue This Year
  • PPBT N/A
  • STKH N/A
  • Revenue Next Year
  • PPBT N/A
  • STKH N/A
  • P/E Ratio
  • PPBT N/A
  • STKH N/A
  • Revenue Growth
  • PPBT N/A
  • STKH N/A
  • 52 Week Low
  • PPBT $0.53
  • STKH $3.84
  • 52 Week High
  • PPBT $13.95
  • STKH $136.80
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 11.95
  • STKH 39.92
  • Support Level
  • PPBT $0.53
  • STKH $4.00
  • Resistance Level
  • PPBT $2.36
  • STKH $5.73
  • Average True Range (ATR)
  • PPBT 0.16
  • STKH 0.69
  • MACD
  • PPBT -0.13
  • STKH 0.15
  • Stochastic Oscillator
  • PPBT 2.05
  • STKH 33.93

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About STKH Steakholder Foods Ltd.

Steakholder Foods Ltd is engaged in transforming the alternative protein industries through its technology. The group specializes in developing and selling 3D-printing production machines, supported by proprietary premix blends, formulated from the highest-quality raw ingredients. These tools help manufacturers of all sizes efficiently produce foods that meet consumer expectations for taste, texture, and appearance and offer a safe and sustainable alternative to industrialized meat and seafood production. The company's expertise in creating alternative protein products replicating traditional meats' complex textures such as beef steaks, white fish, shrimp, and eel. It also explores the integration of cultivated cells, preparing for future advancements in food technology.

Share on Social Networks: